greeksoup/ stock research

Johnson & Johnson (JNJ) FY2022 results: revenue $80.0 billion, up 1.6% on the year

Johnson & Johnson (JNJ) reported revenue of $80.0 billion for fiscal 2022, the year ended 1 January 2023, up 1.6% on the year before. Net income was $17.9 billion, down 14.1%, and diluted earnings per share $6.73. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2023.

Revenue
$80.0 billion
+1.6% on the year
FY2015FY2022
Operating margin
n/a
FY2015FY2022
Net income
$17.9 billion
-14.1% on the year
FY2015FY2022
Diluted EPS
$6.73
-13.8% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue79,99078,74082,584+1.6%
Cost of revenue24,59623,40228,427+5.1%
Gross profit55,39455,33854,157+0.1%
Gross margin69.3%70.3%65.6%
Research and development0.00.012,159
Selling, general and administrative20,24620,11822,084+0.6%
Interest expense276183201+50.8%
Pre-tax income19,35919,17816,497+0.9%
Income tax2,9891,3771,783+117.1%
Effective tax rate15.4%7.2%10.8%
Net income17,94120,87814,714-14.1%
Net margin22.4%26.5%17.8%
Diluted EPS$6.73$7.81$5.51-13.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow21,19423,41023,536-9.5%
Capital expenditure4,0093,6523,347+9.8%
Free cash flow17,18519,75820,189-13.0%
Free cash flow margin21.5%25.1%24.4%
Cash from investing-12,371-8,683-20,825
Cash from financing-8,871-14,047-6,120
Depreciation and amortisation6,9707,3907,231-5.7%
Share-based compensation1,1381,1351,005+0.3%
Buybacks6,0353,4563,221+74.6%
Dividends paid11,68211,03210,481+5.9%
Dividend per share$4.45$4.19$3.98+6.2%
Diluted shares, weighted2,664m2,674m2,671m-0.4%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity76,80474,02363,278+3.8%
Non-controlling interest0.0n/an/a
Debt39,64233,75135,266+17.5%
Other liabilities70,93274,24476,350-4.5%
Total liabilities and equity187,378182,018174,894+2.9%
Fixed assets17,98218,96218,766-5.2%
Goodwill36,04725,43636,393+41.7%
Intangible assets38,48946,39253,402-17.0%
Investments9,39217,12111,200-45.1%
Cash and equivalents12,88914,48713,985-11.0%
Receivables14,03915,28313,576-8.1%
Inventory10,26810,3879,344-1.1%
Other assets48,27233,95018,228+42.2%
Total assets187,378182,018174,894+2.9%

10-K for the year ended 1 January 2023, filed 16 February 2023: the filing.